[go: up one dir, main page]

Holt et al., 1990 - Google Patents

Protective effect of sera raised against different fractions of Streptococcus suis type 2

Holt et al., 1990

Document ID
1264407857936064290
Author
Holt M
Enright M
Alexander T
Publication year
Publication venue
Journal of comparative pathology

External Links

Snippet

Summary Five bands of 44, 54, 78, 86 and 94 kD were identified by Western blot analysis of Streptococcus suis type 2 by the use of sera that were from immune or non-immune pigs and were positive or negative in bactericidal tests in vitro. These bands were cut from the gels …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Karakawa et al. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes
Glatman-Freedman et al. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis
Fox et al. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers
ES2198405T3 (en) TYPE I SURFACE ANTIGENS ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIS.
Minden et al. Shared antigens between heterologous bacterial species
Hanff et al. Humoral immune response in experimental syphilis to polypeptides of Treponema pallidum.
Holt et al. Protective effect of sera raised against different fractions of Streptococcus suis type 2
Thomas et al. Studies on primary atypical pneumonia. II. Observations concerning the relationship of a non-hemolytic streptococcus to the disease
Crowder et al. Type-specific immunity in pseudomonas diseases
Tomer et al. Comparative analysis of the outer membrane protein profiles of isolates of the Pasteurella multocida (B: 2) associated with haemorrhagic septicaemia
Blanco et al. The antigenic interrelationship between the endoflagella of Treponema phagedenis biotype Reiter and Treponema pallidum Nichols strain. I. Treponemicidal activity of cross-reactive endoflagellar antibodies against T. pallidum.
Józefczyk Specific human antibodies to enterotoxins A, B, and C1 of Staphylococcus: their increased synthesis in staphylococcal infection
Buchanan et al. Immunity to gonococcal infection induced by vaccination with isolated outer membranes of Neisseria gonorrhoeae in guinea pigs
Holt et al. Studies of the protective effect of different fractions of sera from pigs immune to Streptococcus suis type 2 infection
LINDÉN MOUSE‐PROTECTIVE EFFECT OF RABBIT ANTI‐R‐PROTEIN ANTIBODIES AGAINST GROUP B STREPTOCOCCI TYPE II CARRYING R‐PROTEIN: Lack of Effect on Type III Carrying R‐Protein
De Cueninck et al. Type-specific protection of neonatal rats from lethal group B streptococcal infection by immune sera obtained from human volunteers vaccinated with type III-specific polysaccharide
Kelly Immunotherapy against antibiotic-resistant bacteria: the Russian experience with an antistaphylococcal hyperimmune plasmaand immunoglobulin
Myerowitz et al. Induction of Haemophilus influenzae type b capsular antibody in neonatal rabbits by gastrointestinal colonization with cross-reacting Escherichia coli
Finland et al. Reactions of human subjects to the injection of purified type specific pneumococcus polysaccharides
Scott et al. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome
Seibert The interplay of an immune substance with tuberculopolysaccharide and its antibody in tuberculosis
Onderdonk et al. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis
Crumrine et al. Immunochemical cross-reactions between type III group B streptococcus and type 14 Streptococcus pneumoniae
Knöll et al. Tissue Cages for Study of Experimental Streptococcal Infection in Rabbits: I. Production of Erythrogenic Toxins in vivo
US4539201A (en) Medicament and method for inducing immunity to infectious bovine keratoconjunctivitis